Key result
Autopsy of an 18-year-old male with left ventricular non-compaction cardiomyopathy who died from sudden ventricular fibrillation revealed myocardial infarction and extensive fibrosis.
Why the study?
Left ventricular non-compaction cardiomyopathy (LVNC) is a rare cardiac disease with potential lethality due to arrhythmia and myocardial infarction leading to sudden cardiac death, requiring better understanding of its clinical implications.
Case Report (n=1)
This case highlights that left ventricular non-compaction cardiomyopathy can lead to sudden cardiac death due to electrical heterogeneity and myocardial infarction, even in patients with a primary-prevention ICD.
Left ventricular non-compaction cardiomyopathy (LVNC) is a rare cardiac disease. This study presents a rare case of an 18-year-old male who died following sudden ventricular fibrillation, with LVNC identified at autopsy. The patient had a known clinical diagnosis of LVNC and a primary-prevention implantable cardioverter-defibrillator (ICD), with a left ventricular ejection fraction of 35-40%. Gross autopsy findings revealed increased trabeculation in the left ventricle, dark color changes in the trabecular muscles, and evidence of ischaemia in the anterior papillary muscle. Histopathological examination of the anterior papillary muscle showed myocardial infarction consistent with the first 24 hours post-infarction, hypertrophy in the trabecular muscles, and extensive perivascular, interstitial, and subendocardial fibrosis with positive Masson's trichrome staining. Widespread pulmonary edema, fibrin thrombi in the brachiocephalic vein, and fibrin thrombi within small blood vessel lumens were detected. This case emphasizes that LVNC is a potentially lethal disease due to electrical heterogeneity creating a re-entry arrhythmia substrate and a predisposition to myocardial infarction, which may lead to sudden cardiac death. When investigating sudden cardiac death cases in young patients, LVNC should be included in the differential diagnosis. Early diagnosis, appropriate cardiac monitoring, and preventive treatments such as the use of implantable cardioverter-defibrillators play a critical role in reducing the risk of sudden death. Postmortem genetic testing of the deceased and genetic counseling of first-degree relatives should be an integral part of management.
No takes yet. Share an insight, caveat, or question.
Buğra et al. (2026) conducted a case report in Left ventricular non-compaction cardiomyopathy (LVNC) (n=1). Left ventricular non-compaction cardiomyopathy was evaluated on Autopsy findings following sudden cardiac death. Autopsy of an 18-year-old male with left ventricular non-compaction cardiomyopathy who died from sudden ventricular fibrillation revealed myocardial infarction and extensive fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: